These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 23612359)

  • 21. [The effects of amniotic membrane on corneal penetration of ofloxacin].
    Xu JJ; Wang Y
    Zhonghua Yan Ke Za Zhi; 2006 Jul; 42(7):624-7. PubMed ID: 17081422
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Study of ocular pharmacokinetics of in situ gel system for S(-)-satropane evaluated by microdialysis.
    Fu J; Feng X; Yuan H; Yan L; Kuang X; Xia Z; Gao X; Yu C; Lu Y; Chen HZ
    J Pharm Biomed Anal; 2008 Nov; 48(3):840-3. PubMed ID: 18632240
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In situ gelling systems: a strategy to improve the bioavailability of ophthalmic pharmaceutical formulations.
    Almeida H; Amaral MH; Lobão P; Lobo JM
    Drug Discov Today; 2014 Apr; 19(4):400-12. PubMed ID: 24120893
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sustained ophthalmic delivery of ofloxacin from a pH triggered in situ gelling system.
    Srividya B; Cardoza RM; Amin PD
    J Control Release; 2001 Jun; 73(2-3):205-11. PubMed ID: 11516498
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of chitosan and of N-carboxymethylchitosan on intraocular penetration of topically applied ofloxacin.
    Di Colo G; Zambito Y; Burgalassi S; Nardini I; Saettone MF
    Int J Pharm; 2004 Apr; 273(1-2):37-44. PubMed ID: 15010128
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Corneal pharmacokinetics of topically applied azithromycin and clarithromycin.
    Kuehne JJ; Yu AL; Holland GN; Ramaswamy A; Taban R; Mondino BJ; Yu F; Rayner SA; Giese MJ
    Am J Ophthalmol; 2004 Oct; 138(4):547-53. PubMed ID: 15488779
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Penetration of second-, third-, and fourth-generation topical fluoroquinolone into aqueous and vitreous humour in a rabbit endophthalmitis model.
    Yağci R; Oflu Y; Dinçel A; Kaya E; Yağci S; Bayar B; Duman S; Bozkurt A
    Eye (Lond); 2007 Jul; 21(7):990-4. PubMed ID: 16732216
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ciprofloxacin and ofloxacin aqueous humor concentrations after topical administration in dogs undergoing cataract surgery.
    Yu-Speight AW; Kern TJ; Erb HN
    Vet Ophthalmol; 2005; 8(3):181-7. PubMed ID: 15910371
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Systemic absorption pathways of topically applied beta adrenergic antagonists in the pigmented rabbit.
    Lee YH; Kompella UB; Lee VH
    Exp Eye Res; 1993 Sep; 57(3):341-9. PubMed ID: 7901046
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design and evaluation of thermoreversible in situ gelling system of forskolin for the treatment of glaucoma.
    Gupta S; Samanta MK
    Pharm Dev Technol; 2010; 15(4):386-93. PubMed ID: 19772380
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Study of an alginate/HPMC-based in situ gelling ophthalmic delivery system for gatifloxacin.
    Liu Z; Li J; Nie S; Liu H; Ding P; Pan W
    Int J Pharm; 2006 Jun; 315(1-2):12-7. PubMed ID: 16616442
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Applications of poloxamers in ophthalmic pharmaceutical formulations: an overview.
    Almeida H; Amaral MH; Lobão P; Sousa Lobo JM
    Expert Opin Drug Deliv; 2013 Sep; 10(9):1223-37. PubMed ID: 23688342
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics of topically applied ciprofloxacin in rabbit tears.
    Green LC; Callegan MC; Engel LS; Shimomura Y; Jasheway DW; O'Callaghan RJ; Hill JM
    Jpn J Ophthalmol; 1996; 40(1):123-6. PubMed ID: 8739510
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The bioavailability of ofloxacin from several formulations.
    Flor S; Beals B
    Curr Med Res Opin; 1991; 12(5):282-6. PubMed ID: 2004540
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improved corneal bioavailability of ofloxacin: biodegradable microsphere-loaded ion-activated in situ gel delivery system.
    Sayed EG; Hussein AK; Khaled KA; Ahmed OA
    Drug Des Devel Ther; 2015; 9():1427-35. PubMed ID: 25792803
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Two open-label, randomized, crossover studies assessing the bioequivalence of ofloxacin administered as immediate-and extended-release formulations in healthy subjects.
    Marier JF; Ducharme MP; DiMarco M; Di Spirito M; Morelli G; Tippabhotla SK; Badri N; Rampal A; Monif T
    Clin Ther; 2006 Dec; 28(12):2070-80. PubMed ID: 17296463
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effects of pilocarpine in new ophthalmic formulations on intraocular pressure in rabbits with ocular hypertension].
    Xu Y; Chen Z; Song J
    Zhonghua Yan Ke Za Zhi; 2002 Dec; 38(12):721-4. PubMed ID: 12654220
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative tear concentrations of topically applied ciprofloxacin, ofloxacin, and norfloxacin in human eyes.
    Akkan AG; Mutlu I; Ozyazgan S; Gök A; Yigit U; Ozüner Z; Senses V; Pekel H
    Int J Clin Pharmacol Ther; 1997 May; 35(5):214-7. PubMed ID: 9174877
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ocular hypotensive efficacy, safety and systemic absorption of AR-12286 ophthalmic solution in normal volunteers.
    Kopczynski C; Novack GD; Swearingen D; van Haarlem T
    Br J Ophthalmol; 2013 May; 97(5):567-72. PubMed ID: 23435190
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bioequivalence study of two azithromycin formulations in healthy subjects.
    Setiawati E; Deniati SH; Yunaidi DA; Handayani LR; Harinanto G; Santoso ID; Sari AP; Rimainar A
    Arzneimittelforschung; 2009; 59(9):471-5. PubMed ID: 19856795
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.